FIG. 1.

Overview of Survey and Questions. ^aScreening questions also included consent to participate and determined qualification to participate in the remainder of the study. ^bParticipants who did not meet eligibility criteria did not see questions included in Part II of the survey. ^cBased on responses to the UFS-QOL and select questions from the AMSS portion of the Screener (Part I), severe or moderate uterine fibroids were defined as at least a moderate or higher score on both transformed UFS-QOL measures (Symptom Severity ≥36.5 and HRQOL Total Score ≤72.5) and the AMSS (≥40.5) or a severe score on at least one of the following metrics: UFS-QOL Symptom Severity ≥56.5, UFS-QOL HRQOL Total Score ≤50.5, or AMSS ≥72.5. AMSS, Aberdeen Menorrhagia Severity Scale; HCP, healthcare provider; UFS-QOL, Uterine Fibroid Symptom and Health-Related Quality of Life.